bibliographic resource 8212790 [br/8212790]
https://w3id.org/oc/corpus/br/8212790
- is a
-
- title
-
- A phase I/II study of dovitinib (TKI258), a FGFR and VEGFR inhibitor, in patients (pts) with advanced or metastatic renal cell cancer: Phase I results.
- publication date
-
- contributor
-
- format
-
- identifier
-
- part of
-